ARK Investment Management (Cathie Wood) — NRIX Trade History
Quarter-by-quarter changes in the Nurix Therapeutics Inc position · CUSIP 67080M103
Currently held · 4.8 YearsFirst seen: 2021 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 1,793,196 | 72,061 | +4.2% | $43.5M | 0.28% |
| 2026 Q1 | 2026-05-12 | Add | 1,721,135 | 118,596 | +7.4% | $26.7M | 0.21% |
| 2025 Q4 | 2026-02-11 | Add | 1,602,539 | 92,135 | +6.1% | $30.4M | 0.20% |
| 2025 Q3 | 2025-11-12 | Reduce | 1,510,404 | -64,628 | -4.1% | $14.0M | 0.08% |
| 2025 Q2 | 2025-07-30 | Reduce | 1,575,032 | -15,878 | -1.0% | $17.9M | 0.13% |
| 2025 Q1 | 2025-05-07 | Add | 1,590,910 | 60,617 | +4.0% | $18.9M | 0.19% |
| 2024 Q4 | 2025-02-04 | Reduce | 1,530,293 | -686,072 | -31.0% | $28.8M | 0.24% |
| 2024 Q3 | 2024-10-31 | Reduce | 2,216,365 | -106,967 | -4.6% | $49.8M | 0.46% |
| 2024 Q2 | 2024-07-26 | Reduce | 2,323,332 | -312,006 | -11.8% | $48.5M | 0.43% |
| 2024 Q1 | 2024-04-18 | Reduce | 2,635,338 | -559,661 | -17.5% | $38.7M | 0.27% |
| 2023 Q4 | 2024-01-17 | Add | 3,194,999 | 601,952 | +23.2% | $33.0M | 0.20% |
| 2023 Q3 | 2023-10-18 | Add | 2,593,047 | 331,976 | +14.7% | $20.4M | 0.16% |
| 2023 Q2 | 2023-07-10 | Add | 2,261,071 | 21,212 | +0.9% | $22.6M | 0.15% |
| 2023 Q1 | 2023-04-17 | Add | 2,239,859 | 251,605 | +12.7% | $19.9M | 0.14% |
| 2022 Q4 | 2023-01-24 | Add | 1,988,254 | 701,732 | +54.5% | $21.8M | 0.19% |
| 2022 Q3 | 2022-10-17 | Add | 1,286,522 | 507,797 | +65.2% | $16.8M | 0.12% |
| 2022 Q2 | 2022-07-11 | Add | 778,725 | 386,734 | +98.7% | $7.9M | 0.05% |
| 2022 Q1 | 2022-04-19 | Add | 391,991 | 348,044 | +792.0% | $5.5M | 0.02% |
| 2021 Q4 | 2022-01-28 | New | 43,947 | 43,947 | — | $1.3M | 0.00% |
| 2021 Q3 | 2021-11-12 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-05 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-13 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-10-30 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-11 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-01-31 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-12 | — | — | — | — | — | — |
| 2019 Q2 | 2019-07-30 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-13 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-11 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-07 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-07 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-14 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-12 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-09 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-11 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.